8124

    532331

    AJANTPHARM

    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    AJANTA PHARMA LIMITED Share Price Today

    AJANTA PHARMA LIMITED is currently trading at ₹3437.5, down by ₹87.6 from the previous close. The stock touched an intraday high of ₹3527.90 and a low of ₹3403.10 during the latest trading session. Over the past one year, AJANTA PHARMA LIMITED has delivered a return of 33.71%, while the stock has gained 4.49% in the last one month.

    AJANTA PHARMA LIMITED performance

    Today’s low Today’s high
    ₹ 3403.10 ₹ 3527.90
    ₹ 3439.80
    52 week low 52 week high
    ₹ 2329.90 ₹ 3598.80
    ₹ 3439.80
    Open Price ₹ 3525.10
    Prev. Close ₹ 3525.10
    Volume (Shares) 123523.00
    Total traded value ₹ 4248.94
    Upper Circuit ₹ 4191.70
    Lower Circuit ₹ 2794.50
    info

    Investment Returns

    Over 1 Month 4.49% Over 3 Months 21.52% Over 6 Months 24.94% Over 1 Year 33.71%
    Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    AJANTA PHARMA LIMITED fundamentals


    • Market cap (Cr) 42,940.90
    • P/E Ratio (TTM) 43.70
    • Beta 0.54
    • Book Value / share 337.98
    • Return on equity 24.13%
    • EPS (TTM) 80.61
    • Dividend yield 0.80%
    • Net profit/quarter (Cr) 315.47
    info icon alternate text
    • Market cap (Cr) 42,949.70
    • P/E Ratio (TTM) 43.70
    • Beta 0.52
    • Book Value / share 337.98
    • Return on equity 24.13%
    • EPS (TTM) 80.61
    • Dividend yield 0.80%
    • Net profit/quarter (Cr) 315.47
    info icon alternate text

    AJANTA PHARMA LIMITED Financials

    Open financial information
    Revenue
    Net income
    Particulars JUN 2026 (Values in Cr)
    Revenue 1488.67
    Operating Expense 1136.04
    Net Profit 315.47
    Net Profit Margin (%) 21.19
    Earnings Per Share (EPS) 25.25
    EBITDA 467.52
    Effective Tax Rate (%) 25.50
    Particulars MAR 2026 (Values in Cr)
    Revenue 1210.53
    Operating Expense 1015.90
    Net Profit 197.28
    Net Profit Margin (%) 16.29
    Earnings Per Share (EPS) 15.79
    EBITDA 301.03
    Effective Tax Rate (%) 23.41
    Particulars DEC 2025 (Values in Cr)
    Revenue 1206.59
    Operating Expense 909.89
    Net Profit 245.04
    Net Profit Margin (%) 20.30
    Earnings Per Share (EPS) 19.61
    EBITDA 366.71
    Effective Tax Rate (%) 24.00
    Particulars SEP 2025 (Values in Cr)
    Revenue 1220.24
    Operating Expense 973.30
    Net Profit 249.53
    Net Profit Margin (%) 20.44
    Earnings Per Share (EPS) 19.98
    EBITDA 364.62
    Effective Tax Rate (%) 22.49
    Particulars JUN 2025 (Values in Cr)
    Revenue 1208.56
    Operating Expense 920.20
    Net Profit 254.97
    Net Profit Margin (%) 21.09
    Earnings Per Share (EPS) 20.41
    EBITDA 370.03
    Effective Tax Rate (%) 22.49
    Particulars MAR 2026 (Values in Cr)
    Revenue 4845.92
    Operating Expense 3819.29
    Net Profit 946.82
    Net Profit Margin (%) 19.53
    Earnings Per Share (EPS) 75.79
    EBITDA 1402.38
    Effective Tax Rate (%) 23.08
    Particulars MAR 2025 (Values in Cr)
    Revenue 4322.04
    Operating Expense 3261.85
    Net Profit 916.89
    Net Profit Margin (%) 21.21
    Earnings Per Share (EPS) 73.28
    EBITDA 1324.59
    Effective Tax Rate (%) 22.30
    Particulars MAR 2024 (Values in Cr)
    Revenue 3971.12
    Operating Expense 2990.65
    Net Profit 807.24
    Net Profit Margin (%) 20.32
    Earnings Per Share (EPS) 64.11
    EBITDA 1235.91
    Effective Tax Rate (%) 26.41
    Particulars MAR 2023 (Values in Cr)
    Revenue 3411.27
    Operating Expense 2844.17
    Net Profit 558.72
    Net Profit Margin (%) 16.37
    Earnings Per Share (EPS) 43.61
    EBITDA 832.03
    Effective Tax Rate (%) 20.16
    Particulars MAR 2022 (Values in Cr)
    Revenue 3140.64
    Operating Expense 2379.83
    Net Profit 719.86
    Net Profit Margin (%) 22.92
    Earnings Per Share (EPS) 55.52
    EBITDA 1030.62
    Effective Tax Rate (%) 20.06
    Particulars MAR 2026 (Values in Cr)
    Book Value / Share 361.16
    ROE % 25.39
    ROCE % 31.81
    Total Debt to Total Equity 0.04
    EBITDA Margin 28.74
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 302.38
    ROE % 25.02
    ROCE % 31.98
    Total Debt to Total Equity 0.01
    EBITDA Margin 29.13
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 282.34
    ROE % 23.47
    ROCE % 31.59
    Total Debt to Total Equity 0.01
    EBITDA Margin 29.86
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 268.14
    ROE % 17.68
    ROCE % 22.21
    Total Debt to Total Equity 0.01
    EBITDA Margin 23.56
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 380.24
    ROE % 22.77
    ROCE % 28.91
    Total Debt to Total Equity 0.01
    EBITDA Margin 31.28
    Particulars MAR 2026 (Values in Cr)
    Book Value / Share 336.94
    ROE % 24.13
    ROCE % 30.64
    Total Debt to Total Equity 0.01
    EBITDA Margin 28.94
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 289.21
    ROE % 26.05
    ROCE % 32.78
    Total Debt to Total Equity 0.01
    EBITDA Margin 30.65
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 270.17
    ROE % 24.24
    ROCE % 32.49
    Total Debt to Total Equity 0.01
    EBITDA Margin 31.12
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 256.94
    ROE % 17.42
    ROCE % 21.63
    Total Debt to Total Equity 0.01
    EBITDA Margin 24.39
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 369.15
    ROE % 23.78
    ROCE % 29.60
    Total Debt to Total Equity 0.01
    EBITDA Margin 32.82
    Particulars MAR 2026 (Values in Cr)
    Cash & Short Term Investments 104.77
    Total Assets 6154.84
    Total Liabilities 6154.84
    Total Equity 4527.09
    Share Outstanding 12
    Price to Book Ratio 8.32
    Return on Assets (%) 17.15
    Return on Capital (%) 22.28
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 176.24
    Total Assets 5014.95
    Total Liabilities 5014.95
    Total Equity 3790.29
    Share Outstanding 12
    Price to Book Ratio 9.05
    Return on Assets (%) 18.35
    Return on Capital (%) 24.27
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 130.77
    Total Assets 4638.39
    Total Liabilities 4638.39
    Total Equity 3567.36
    Share Outstanding 12
    Price to Book Ratio 8.28
    Return on Assets (%) 17.59
    Return on Capital (%) 22.87
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 330.90
    Total Assets 4679.02
    Total Liabilities 4679.02
    Total Equity 3387.99
    Share Outstanding 12
    Price to Book Ratio 4.71
    Return on Assets (%) 12.56
    Return on Capital (%) 17.35
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 211.79
    Total Assets 4055.58
    Total Liabilities 4055.58
    Total Equity 3264.34
    Share Outstanding 8
    Price to Book Ratio 4.90
    Return on Assets (%) 17.57
    Return on Capital (%) 21.82
    Particulars MAR 2026 (Values in Cr)
    Cash & Short Term Investments 90.55
    Total Assets 5316.72
    Total Liabilities 5316.72
    Total Equity 4223.53
    Share Outstanding 12
    Price to Book Ratio 8.32
    Return on Assets (%) 17.80
    Return on Capital (%) 22.42
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 49.72
    Total Assets 4554.25
    Total Liabilities 4554.25
    Total Equity 3625.31
    Share Outstanding 12
    Price to Book Ratio 9.05
    Return on Assets (%) 20.13
    Return on Capital (%) 25.29
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 63.06
    Total Assets 4217.44
    Total Liabilities 4217.44
    Total Equity 3413.57
    Share Outstanding 12
    Price to Book Ratio 8.28
    Return on Assets (%) 19.14
    Return on Capital (%) 23.65
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 269.92
    Total Assets 4304.79
    Total Liabilities 4304.79
    Total Equity 3246.45
    Share Outstanding 12
    Price to Book Ratio 4.71
    Return on Assets (%) 12.97
    Return on Capital (%) 17.21
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 145.25
    Total Assets 3780.49
    Total Liabilities 3780.49
    Total Equity 3169.18
    Share Outstanding 8
    Price to Book Ratio 4.90
    Return on Assets (%) 19.04
    Return on Capital (%) 22.71
    Particulars MAR 2026 (Values in Cr)
    Net Income 1377.65
    Cash from Operations 888.18
    Cash from Investing -428.92
    Cash from Financing -167.92
    Net change in Cash -67.65
    Free Cash Flow 1253.34
    Particulars MAR 2025 (Values in Cr)
    Net Income 1189.16
    Cash from Operations 1480.20
    Cash from Investing -376.52
    Cash from Financing -733.41
    Net change in Cash 47.30
    Free Cash Flow 1798.12
    Particulars MAR 2024 (Values in Cr)
    Net Income 1113.93
    Cash from Operations 1097.20
    Cash from Investing 65.39
    Cash from Financing -1051.06
    Net change in Cash -200.60
    Free Cash Flow 1249.61
    Particulars MAR 2023 (Values in Cr)
    Net Income 745.25
    Cash from Operations 943.40
    Cash from Investing -559.60
    Cash from Financing -108.20
    Net change in Cash 124.31
    Free Cash Flow 1117.88
    Particulars MAR 2022 (Values in Cr)
    Net Income 909.48
    Cash from Operations 800.84
    Cash from Investing -74.10
    Cash from Financing -459.71
    Net change in Cash 27.90
    Free Cash Flow 949.68
    Particulars MAR 2026 (Values in Cr)
    Net Income 1231.03
    Cash from Operations 1096.89
    Cash from Investing -399.56
    Cash from Financing -359.62
    Net change in Cash 44.65
    Free Cash Flow 1464.17
    Particulars MAR 2025 (Values in Cr)
    Net Income 1180.06
    Cash from Operations 1335.63
    Cash from Investing -349.60
    Cash from Financing -715.71
    Net change in Cash -11.51
    Free Cash Flow 1652.83
    Particulars MAR 2024 (Values in Cr)
    Net Income 1096.95
    Cash from Operations 987.63
    Cash from Investing 105.02
    Cash from Financing -1047.70
    Net change in Cash -207.33
    Free Cash Flow 1140.20
    Particulars MAR 2023 (Values in Cr)
    Net Income 699.85
    Cash from Operations 861.85
    Cash from Investing -501.31
    Cash from Financing -105.12
    Net change in Cash 129.86
    Free Cash Flow 1037.51
    Particulars MAR 2022 (Values in Cr)
    Net Income 900.54
    Cash from Operations 735.81
    Cash from Investing -66.04
    Cash from Financing -457.30
    Net change in Cash 19.00
    Free Cash Flow 882.33
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENTERPRISES L 42.42 17.60 2.05 325.08 23.12 43.00
    BLISS GVS PHARMA LTD 488.95 39.37 4.35 5194.80 118.35 552.90
    CIPLA LTD. 1450.00 32.73 3.40 117137.57 1165.55 1672.20
    FERMENTA BIOTECH LTD. 546.75 25.57 3.95 1609.14 256.40 551.25
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENTERPRISES L 42.42 29.66 5.46 325.08 23.12 43.00
    AMRUTANJAN HEALTH CARE LTD. 517.35 23.19 4.03 1495.69 490.00 789.95
    ASTRAZENECA PHARMA IND LT 8173.90 106.82 23.41 20434.75 7630.00 9850.00
    BLISS GVS PHARMA LTD 488.95 52.92 4.49 5194.80 118.35 552.90

    AJANTA PHARMA LIMITED shareholding pattern

    Holding
    7.03%
    63.48%
    7.68%
    21.8%
    22.53%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    AJANTA PHARMA LIMITED Technicals Summary

    3436.40 -2.51 redarrow
    red-green-graph indicator
    5 Bearish
    11 Bullish
    • 5 Days 3478.50
    • 26 Days 3386.00
    • 10 Days 3452.70
    • 50 Days 3287.10
    • 12 Days 3445.10
    • 100 Days 3142.80
    • 20 Days 3412.30
    • 200 Days 2989.50
    3510.03 PIVOT
    First Support 3480.07 First Resistance 3543.87 Second Support 3446.23 Second Resistance 3573.83 Third Support 3416.27 Third Resistance 3607.67
    RSI 62.48 ADX 47.24 MACD 59.07 Williams % R -24.75 Commodity Channel Index (CCI) 138.92
    Date 2026-08-04 Week 60637.00 Same Day 42331.00 Month 48769.00
    1 Year 0.55 3 Year 0.46
    Over 1 Month
    4.49% down
    Over 1 Year
    33.71% down
    Over 3 Months
    21.52% down
    Over 3 Years
    26.36% down
    Over 6 Months
    24.94% down
    Over 5 Years
    18.23% down

    AJANTA PHARMA LIMITED Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    05 Aug 2026 32.0 Interim 1 05 Aug 2026 Equity shares
    10 Nov 2025 28.0 Interim 1 10 Nov 2025 Equity shares
    06 Nov 2024 28.0 Interim 1 06 Nov 2024 Equity shares
    08 Feb 2024 26.0 Interim 2 08 Feb 2024 Equity shares
    04 Aug 2023 10.0 Interim 1 04 Aug 2023 Equity shares
    04 Aug 2023 15.0 Special 04 Aug 2023 Equity shares
    11 Nov 2022 7.0 Interim 14 Nov 2022 Equity shares
    09 Nov 2021 9.5 Interim 10 Nov 2021 Equity shares
    12 Nov 2020 9.5 Interim 13 Nov 2020 Equity shares
    15 Nov 2019 13.0 Interim 18 Nov 2019 Equity shares
    09 Nov 2018 9.0 Interim 12 Nov 2018 Equity shares
    23 Mar 2017 7.0 Interim 2 25 Mar 2017 Equity shares
    07 Nov 2016 6.0 Interim 08 Nov 2016 Equity shares
    17 Mar 2016 8.0 Interim 19 Mar 2016 Equity shares
    25 Jun 2015 6.0 Final 27 Jun 2015 Equity shares
    24 Jul 2014 10.0 Final 28 Jul 2014 Equity shares
    18 Jul 2013 6.25 Final 22 Jul 2013 Equity shares
    28 Jun 2012 7.5 Final 02 Jul 2012 Equity shares
    23 Jun 2011 5.0 Final 25 Jun 2011 Equity shares
    29 Jun 2010 3.5 Final 01 Jul 2010 Equity shares
    30 Jun 2009 2.5 Final 03 Jul 2009 Equity shares
    27 Jun 2008 2.5 Final 01 Jul 2008 Equity shares
    19 Sep 2007 2.0 Final 21 Sep 2007 Equity shares
    Ex-Date Ex-Bonus Ratio
    23 Jun 2022 22 Jun 2022 1:2
    18 Sep 2013 17 Sep 2013 1:2
    Ex-Date Old FV NEW FV Record Date
    20 Mar 2015 5.0 2.0 23 Mar 2015
    09 Aug 2012 10.0 5.0 10 Aug 2012
    Dividend date Dividend amount Dividend type Record date Instrument type
    05 Aug 2026 32.0 Interim 1 05 Aug 2026 Equity shares
    10 Nov 2025 28.0 Interim 1 10 Nov 2025 Equity shares
    06 Nov 2024 28.0 Interim 1 06 Nov 2024 Equity shares
    08 Feb 2024 26.0 Interim 2 08 Feb 2024 Equity shares
    04 Aug 2023 10.0 Interim 1 04 Aug 2023 Equity shares
    04 Aug 2023 15.0 Special 04 Aug 2023 Equity shares
    11 Nov 2022 7.0 Interim 14 Nov 2022 Equity shares
    09 Nov 2021 9.5 Interim 10 Nov 2021 Equity shares
    12 Nov 2020 9.5 Interim 13 Nov 2020 Equity shares
    15 Nov 2019 13.0 Interim 18 Nov 2019 Equity shares
    09 Nov 2018 9.0 Interim 12 Nov 2018 Equity shares
    23 Mar 2017 7.0 Interim 2 25 Mar 2017 Equity shares
    07 Nov 2016 6.0 Interim 08 Nov 2016 Equity shares
    17 Mar 2016 8.0 Interim 19 Mar 2016 Equity shares
    25 Jun 2015 6.0 Final 27 Jun 2015 Equity shares
    24 Jul 2014 10.0 Final 28 Jul 2014 Equity shares
    18 Jul 2013 6.25 Final 22 Jul 2013 Equity shares
    28 Jun 2012 7.5 Final 02 Jul 2012 Equity shares
    23 Jun 2011 5.0 Final 25 Jun 2011 Equity shares
    29 Jun 2010 3.5 Final 01 Jul 2010 Equity shares
    30 Jun 2009 2.5 Final 03 Jul 2009 Equity shares
    27 Jun 2008 2.5 Final 01 Jul 2008 Equity shares
    19 Sep 2007 2.0 Final 21 Sep 2007 Equity shares
    Ex-Date Ex-Bonus Ratio
    23 Jun 2022 22 Jun 2022 1:2
    18 Sep 2013 17 Sep 2013 1:2
    Ex-Date Old FV NEW FV Record Date
    20 Mar 2015 5.0 2.0 23 Mar 2015
    09 Aug 2012 10.0 5.0 10 Aug 2012

    Top Gainers

    Top Losers

    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Ajanta Pharma Ltd?

    Answer Field

    Ajanta Pharma Ltd share price is for NSE ₹ 3,437.50 & for BSE ₹ 3,435.00 as on Aug 05 2026 03:30 PM.

    What is the Market Cap of Ajanta Pharma Ltd Share?

    Answer Field

    The market cap of Ajanta Pharma Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Aug 05 2026 03:30 PM.

    What is the 52 Week High and Low of Ajanta Pharma Ltd?

    Answer Field

    The 52 Week High and Low of Ajanta Pharma Ltd for NSE is ₹ 3,598.80 and ₹ 2,329.90 and for BSE is ₹ 3,598.40 and ₹ 2,335.00.

    What is 1 year return for Ajanta Pharma Ltd?

    Answer Field

    The 1 year returns on the stock has been 33.71%.

    What is the P/E Ratio of Ajanta Pharma Ltd Share?

    Answer Field

    As on Aug 05 2026 03:30 PM the price-to-earnings (PE) ratio for Ajanta Pharma Ltd share is 43.70.

    What is the PB ratio of Ajanta Pharma Ltd Share?

    Answer Field

    As on Aug 05 2026 03:30 PM, the price-to-book (PB) ratio for Ajanta Pharma Ltd share is 337.98.

    How to Buy Ajanta Pharma Ltd Share?

    Answer Field

    You can trade in Ajanta Pharma Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Ajanta Pharma Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Ajanta Pharma Ltd shares on the Bajaj Broking app, follow these steps:

    1. Login to the Bajaj Broking App

    2. Click on the Search Icon

    3. Search “Ajanta Pharma Ltd”

    4. Click on the BUY icon

    5. Place a buy order specifying the desired quantity of shares.

    6. Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |